Skip to content

Liquorice and Salivary Cortisol

Effects of Liquorice on Salivary Cortisol and Cortisone

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04045015
Enrollment
30
Registered
2019-08-05
Start date
2018-10-16
Completion date
2020-12-31
Last updated
2019-08-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cushing Syndrome, Hypercortisolism

Brief summary

Salivary cortisol is used as a diagnostic analysis in the investigation of suspected Cushings' syndrome. This study evaluates if liqourice intake increases salivary cortisol in healthy individuals. Late night salivary cortisol and cortisone is analysed before, during and after 7 days of liqourice intake in three different doses.

Interventions

DIETARY_SUPPLEMENTLiqourice

Liqourice corresponding to 1.5, 3.0 or 6.0 mg glycyrrhizic acid per kg body weight is taken in the evening during 7 days.

Sponsors

Umeå University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Intervention model description

Each group of 10 individuals uses liqourice for 7 days and late night salivary cortisol and cortisone is analysed before (baseline), during and after (washout) intake.

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* Men and women 18-65 years.

Exclusion criteria

* Known pituitary or adrenal disease * Medication with glucocorticoids (incl. inhalation, nasal, dermal) * Known hypertension or blood pressure \>140/90 at screening * tobacco use * Subjective problems in oral mucosa or saliva * Abnormal diurnal rhythm (awake 03:00 - 05:30) * Difficulties taking liqourice for 3 weeks or refraining from liqourice during 4 weeks

Design outcomes

Primary

MeasureTime frameDescription
Late night salivary cortisolday 1 to day 7 during liqourice intakeSignificantly increased salivary cortisol 23:00 PM compared to baseline (i.e. before start of liqourice intake).
Time to normalization of late night salivary cortisol1-28 days efter liqourice intake is stoppedTime from liqourice intake is stopped until significant increase of late night salivary cortisol from baseline (i.e. assuming outcome 1 is significant increase) is no longer significant.

Secondary

MeasureTime frameDescription
Morning salivary cortisolday 1-2 during liqourice intakeSignificantly increased salivary cortisol 08:00 AM compared to baseline (i.e. before start of liqourice intake).
Late night salivary cortisol/cortisone ratioday 1 to day 7 during liqourice intakeSignificantly increased salivary cortisol 23:00 PM compared to baseline (i.e. before start of liqourice intake).
Time to normalization of late night salivary cortisol/cortisone ratio1-28 days efter liqourice intake is stoppedTime from liqourice intake is stopped until significant increase of late night salivary cortisol from baseline (i.e. assuming outcome 1 is significant increase) is no longer significant.

Countries

Sweden

Contacts

Primary ContactPer Dahlqvist, MD, PhD
per.dahlqvist@umu.se+46-907853390
Backup ContactNils Bäcklund, MD
nils.backlund@umu.se+46-907850000

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026